Radiotracer dose reduction in integrated PET/MR: implications from national electrical manufacturers association phantom studies
- PMID: 25006216
- DOI: 10.2967/jnumed.114.139147
Radiotracer dose reduction in integrated PET/MR: implications from national electrical manufacturers association phantom studies
Abstract
With the replacement of ionizing CT by MR imaging, integrated PET/MR in selected clinical applications may reduce the overall patient radiation dose when compared with PET/CT. Further potential for radiotracer dose reduction, while maintaining PET image quality (IQ) in integrated PET/MR, may be achieved by increasing the PET acquisition duration to match the longer time needed for MR data acquisition. To systematically verify this hypothesis under controlled conditions, this dose-reduction study was performed using a standardized phantom following the National Electrical Manufacturers Association (NEMA) IQ protocol.
Methods: All measurements were performed on an integrated PET/MR whole-body hybrid system. The NEMA IQ phantom was filled with water and a total activity of 50.35 MBq of (18)F-FDG. The sphere-to-background activity ratio was 8:1. Multiple PET data blocks of 20-min acquisition time were acquired in list-mode format and were started periodically at multiples of the (18)F-FDG half-lives. Different sinograms (2, 4, 8, and 16 min in duration) were reconstructed. Attenuation correction of the filled NEMA phantom was performed using a CT-based attenuation map template. The attenuation-corrected PET images were then quantitatively evaluated following the NEMA IQ protocol, investigating contrast recovery, background variability, and signal-to-noise ratio. Image groups with half the activity and twice the acquisition time were evaluated. For better statistics, the experiment was repeated 3 times.
Results: Contrast recovery, background variability, and signal-to-noise ratio remained almost constant over 3 half-life periods when the decreasing radiotracer activity (100%, 50%, 25%, and 12.5%) was compensated by increasing acquisition time (2, 4, 8, and 16 min). The variation of contrast recovery over 3 half-life periods was small (-6% to +7%), with a mean variation of 2%, compared with the reference setting (100%, 2 min). The signal-to-noise ratio of the hot spheres showed only minor variations over 3 half-life periods (5%). Image readers could not distinguish subjective IQ between the different PET acquisition setups.
Conclusion: An approach to reduce the injected radiotracer activity in integrated PET/MR imaging, while maintaining PET IQ, was presented and verified under idealized experimental conditions. This experiment may serve as a basis for further clinical PET/MR studies using reduced radiotracer dose as compared with conventional PET/CT studies.
Keywords: NEMA image quality measurements; PET/MR phantom measurements; integrated PET/MR hybrid imaging; radiotracer dose reduction.
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Similar articles
-
Systematic evaluation of phantom fluids for simultaneous PET/MR hybrid imaging.J Nucl Med. 2013 Aug;54(8):1464-71. doi: 10.2967/jnumed.112.116376. Epub 2013 Jun 21. J Nucl Med. 2013. PMID: 23792278
-
Quality control for quantitative multicenter whole-body PET/MR studies: A NEMA image quality phantom study with three current PET/MR systems.Med Phys. 2015 Oct;42(10):5961-9. doi: 10.1118/1.4930962. Med Phys. 2015. PMID: 26429271
-
Integrated PET/MR breast cancer imaging: Attenuation correction and implementation of a 16-channel RF coil.Med Phys. 2016 Aug;43(8):4808. doi: 10.1118/1.4959546. Med Phys. 2016. PMID: 27487899
-
Integrated PET/MR.J Magn Reson Imaging. 2014 Feb;39(2):243-58. doi: 10.1002/jmri.24523. Epub 2013 Dec 12. J Magn Reson Imaging. 2014. PMID: 24338921 Review.
-
Current image acquisition options in PET/MR.Semin Nucl Med. 2015 May;45(3):192-200. doi: 10.1053/j.semnuclmed.2014.12.001. Semin Nucl Med. 2015. PMID: 25841274 Review.
Cited by
-
Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study.Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1012-24. doi: 10.1007/s00259-015-3007-8. Epub 2015 Apr 16. Eur J Nucl Med Mol Imaging. 2015. PMID: 25876704
-
Reduction of [68Ga]Ga-DOTA-TATE injected activity for digital PET/MR in comparison with analogue PET/CT.EJNMMI Phys. 2024 Mar 15;11(1):27. doi: 10.1186/s40658-024-00629-z. EJNMMI Phys. 2024. PMID: 38488989 Free PMC article.
-
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):92-102. doi: 10.1007/s00259-015-3145-z. Epub 2015 Aug 6. Eur J Nucl Med Mol Imaging. 2016. PMID: 26243264
-
Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM).Eur Radiol. 2018 Oct;28(10):4086-4101. doi: 10.1007/s00330-017-5008-4. Epub 2018 May 2. Eur Radiol. 2018. PMID: 29717368 Free PMC article. Review.
-
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3513-3537. doi: 10.1007/s00259-023-06406-x. Epub 2023 Aug 25. Eur J Nucl Med Mol Imaging. 2023. PMID: 37624384 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical